
    
      Most of type 2 diabetes are characterized by being overweight or obese mainly caused by
      insulin resistance. GLP-1 receptor agonist has been proved to help to lose weight and improve
      insulin resistance. In this study, we suppose that GLP-1 receptor agonist has the effect of
      inducing diabetes remission in newly diagnosed type 2 diabetes who are overweight or obese
      and has its advantages
    
  